Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171794 | SCV000050802 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000171794 | SCV000223209 | benign | not specified | 2016-10-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000206487 | SCV000261359 | benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000250415 | SCV000318401 | benign | Cardiovascular phenotype | 2015-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000625128 | SCV000447219 | likely benign | Cardiac arrhythmia, ankyrin-B-related | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
ARUP Laboratories, |
RCV000589694 | SCV000602497 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589694 | SCV000697749 | likely benign | not provided | 2016-12-19 | criteria provided, single submitter | clinical testing | Variant summary: The ANK2 c.9854T>C (p.Ile3285Thr) variant involves the alteration of a conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 996/121056 control chromosomes (8 homozygotes) at a frequency of 0.0082276, which is approximately 823 times the estimated maximal expected allele frequency of a pathogenic ANK2 variant (0.00001), strong evidence that this variant is a benign polymorphism. The variant has been reported in the literature, without strong evidence for causality. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign/benign. Taken together, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV000625128 | SCV000743828 | likely benign | Cardiac arrhythmia, ankyrin-B-related | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852978 | SCV000995727 | benign | Atrial fibrillation; Cardiomyopathy | 2019-04-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625128 | SCV002525083 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000625128 | SCV002798670 | likely benign | Cardiac arrhythmia, ankyrin-B-related | 2022-04-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000589694 | SCV003916909 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ANK2: BS1, BS2 |
Clinical Genetics, |
RCV000171794 | SCV001924256 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171794 | SCV001952982 | benign | not specified | no assertion criteria provided | clinical testing |